August 5, 2013 9:21 AM | 1 min read |
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Compugen Ltd. (NASDAQ: CGEN) announced today the signing of a collaborationand license agreement for the research, development, and commercialization ofantibody-based therapeutics for cancer immunotherapy against two novelCompugen discovered immune checkpoint regulators. Under the terms of theagreement, Bayer HealthCare (Bayer) and Compugen will jointly pursue apreclinical research program. Subsequently, Bayer will have full control overfurther development and have worldwide commercialization rights for potentialcancer therapeutics.Under the agreement Compugen will receive an upfront payment of USD 10million, and is eligible to receive over USD 500 million in potentialmilestone payments for both programs, not including milestone payments of upto USD 30 million associated with preclinical activities. Additionally,Compugen is also eligible to receive mid to high single digit royalties onglobal net sales of any resulting products under the collaboration.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.